Immunovia nabs California approval for pancreatic cancer test

2020 02 14 01 40 9390 Cancer Pancreatic 400

Physicians in California can order Immunovia’s Immray PanCan-d blood test for the early detection of pancreatic cancer in their patients.

The California Department of Public Health has granted Immunovia a clinical and public health laboratory license for the test, Immunovia said Thursday.

Commercialization of the laboratory-developed test (LDT) was initiated in the U.S. in August 2021.

Page 1 of 34
Next Page